An Overview on Indole Aryl Sulfide/Sulfone (IAS) as Anti-HIV Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

被引：13
|
作者：
Sinha, Arun K. [1 ,2 ,3 ]
Equbal, Danish [1 ,4 ]
Rastogi, Sumit K. [1 ,2 ]
Kumar, Santosh [1 ,2 ]
Kumar, Ravindra [1 ,2 ]
机构：
[1] CSIR, Med & Proc Chem Div, Cent Drug Res Inst, Sect 10,Sitapur Rd, Lucknow 22603, Uttar Pradesh, India
[2] Acad Sci & Innovat Res AcSIR, Ghaziabad 201002, India
[3] Kolhan Univ Chaibasa, Chaibasa 833201, Jharkhand, India
[4] Sai Life Sci Ltd, Proc R&D, Hyderabad 500010, Telangana, India
来源：
ASIAN JOURNAL OF ORGANIC CHEMISTRY | 2022年 / 11卷 / 04期
关键词：
Arbidol; Indolearylsulfone; NNRTIs; Structure Activity Relationship (SAR); HUMAN-IMMUNODEFICIENCY-VIRUS; TUBULIN POLYMERIZATION; BIOLOGICAL EVALUATION; HIGHLY POTENT; WILD-TYPE; INDOLYLARYLSULFONES; DERIVATIVES; SULFONES; DESIGN; DISCOVERY;
D O I：
10.1002/ajoc.202100744
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
Sulfur-containing indoles are widely studied against different biological targets. Among several potential drug candidates, seven molecules of this class are in the current market and a few of them are either in pipeline or in different stages of clinical trials. Particularly, arylthioindoles or indolylarylsulfones (IAS) received great attention by medicinal chemists due to their pharmokinetic profiles and wide spectrum of biological activities like antiviral, anticancer, cardiovascular, and antibacterial properties. This review summarizes the developmental process, synthesis and structure activity relationship (SAR) around arylthioindole/indolylaryl sulfone scaffolds for antiviral/anti-HIV non-nucleoside reverse transcriptase inhibitor (NNRTIs) activities. It also offers perspective for further development of 3-indolylarylsulfones as an anti-viral agent including their potential against novel COVID-19 infection.
引用
收藏
页数：12
相关论文
共 50 条
  • [41] Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs)
    Hang, Julie Q.
    Li, Yu
    Yang, Yanli
    Cammack, Nick
    Mirzadegan, Tara
    Klumpp, Klaus
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 352 (02) : 341 - 350
  • [42] Non-nucleoside reverse transcriptase inhibitors: a review
    Waters, L.
    John, L.
    Nelson, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (01) : 105 - 118
  • [43] Non-nucleoside reverse transcriptase inhibitors pharmacology
    Garrafo, R.
    VIROLOGIE, 2008, 12 : S15 - S28
  • [44] Molecular dynamics simulations and docking of non-nucleoside reverse transcriptase inhibitors (NNRTIs): a possible approach to personalized HIV treatment
    Florian D Roessler
    Oliver Korb
    Andreas Bender
    Werner Maentele
    Peter J Bond
    Journal of Cheminformatics, 4 (Suppl 1)
  • [45] Non-nucleoside HIV-1 reverse transcriptase inhibitors (NNRTIs): a class of potent molecules enriched by a novel generation
    Pacanowski, J.
    Girard, P. -M.
    VIROLOGIE, 2008, 12 : S3 - S5
  • [46] Resistance to non-nucleoside inhibitors of HIV-I reverse transcriptase
    Bacheler, LT
    DRUG RESISTANCE UPDATES, 1999, 2 (01) : 56 - 67
  • [47] Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors
    Sluis-Cremer, Nicolas
    Tachedjian, Gilda
    VIRUS RESEARCH, 2008, 134 (1-2) : 147 - 156
  • [48] QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Duchowicz, Pablo R.
    Fernandez, Michael
    Caballero, Julio
    Castro, Eduardo A.
    Fernandez, Francisco M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (17) : 5876 - 5889
  • [49] Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1
    Moreno, S
    Casado, JL
    Pérez-Elias, MI
    Dronda, F
    Antela, A
    Moreno, A
    Gutiérrez, C
    AIDS, 2003, 17 (09) : 1413 - 1414
  • [50] HIV resistance to nevirapine and other non-nucleoside reverse transcriptase inhibitors
    Wainberg, MA
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 : S2 - S7
12345